Manufacturer record
J.M. Laboratories: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
16 batches manufactured by J.M. Laboratories (Himachal Pradesh) were declared Not of Standard Quality between February 2021 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
16 records linked to J.M. Laboratories in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Clopidogrel & Aspirin Tablets | GT31923CMfg 2026-02 · Exp 2028-01 | Free salicylic Acid (12.01%) and Content of Aspirin (77.13%)Other | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Cefuroxime Axetil & Potassium Clavulanate Tablets I.P. | CXCA25014EMfg 2025-08 · Exp 2027-01 | The sample does not conform to I.P. with respect to the tests of Dissolution and Assay of Cefuroxime and Clavulanic Acid.Assay | CDL, KolkataCDSCO lab | Jul 2026 |
| Pioglitazone Hydrochloride Tablets IP | GT27476AMfg 2025-08 · Exp 2027-07 | Test for DissolutionDissolution | DTL, Bengaluru, KarnatakaState lab | Mar 2026 |
| (Paracetamol, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Tablets) | GT27292CMfg 2025-08 · Exp 2027-07 | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab | Mar 2026 |
| Aceclofenac & Paracetamol Tablets | GT18022BMfg 2025-02 · Exp 2027-01 | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab | Feb 2026 |
| Calcium Carbonate & Vitamin D3 Tablets IP | GT17894CMfg 2025-02 · Exp 2027-01 | The sample does not conform to claim as per IP 2022 in respect to the Test of Uniformity of content of Vitamin D3Uniformity of weight/content | RDTL, ChandigarhCDSCO lab | Jan 2026 |
| Amoxycillin & Potassium Clavulanate Tablets IP(Amoxheal ? 625 ) | ACAA24149CMfg 2025-01 · Exp 2026-06 | The sample does not conform to standard quality in respect of the test for Dissolution & Assay of Amoxycillin performed.Assay | SDTL, Govt. of Tripura, Agartala. State- TripuraState lab | Dec 2025 |
| Aceclofenac & Paracetamol Tablets | GT16375AMfg 2024-11 · Exp 2026-10 | It fails the test Dissolution and Assay as per IP.Assay | RDTL ErnakulamState lab | Nov 2025 |
| Calcium Carbonate & Vitamin D3 Tablets I.P (DPCAL-500) | GT17894CMfg 2025-02 · Exp 2027-01 | Test for Dissolution for Calcium and Assay for Vitamin D3Assay | DTL, Bengaluru, KarnatakaState lab | Oct 2025 |
| Tablets, Betahistine Tablets I.P. | GT17056AMfg 2024-12 · Exp 2026-11 | Description of TabletsDescription | Drugs Control Laboratory, TelanganaState lab | Jul 2025 |
| Amoxycillin and Potassium Clavulanate Oral Suspension RIGHTCLAV 228.5 Dry Syrup | ACAG24001EMfg 2024-04 · Exp 2025-09 | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate oral suspension with respect to pH and the content of Clavulanic Acid in Potassium Clavulanate dilutedpH | Drugs Testing Laboratory, Madurai-19State lab | May 2025 |
| Phytorab-DSR Capsules | GC 41481Mfg 2023-06 · Exp 2025-05 | The content of rabeprazole sodium in the sample is less (i.e. 55.00% of the labelled amount) than the permissible limitsLabelling | CDTL MumbaiCDSCO lab | Apr 2025 |
| Cefixime & Ofloxacin Tablets (CEPHAFLU- 400) | CT5853AMfg 2024-03 · Exp 2026-02 | Assay of CefiximeAssay | CDL KolkataCDSCO lab | Jan 2025 |
| Torsemide Tablets IP (Torverge-10 Tablets) | GT7137AMfg 2023-03 · Exp 2025-02 | Assay of Torsemide (86.85%)Assay | RDTL ChandigarhState lab | Oct 2024 |
| Torsemide Tablets IP 10 mg (Torverge- 10 Tablets) | GT7137AMfg 2023-03 · Exp 2025-02 | Assay of TorsemideAssay | RDTL ChandigarhCDSCO lab | Sep 2024 |
| Cefpodoxime Proxetil Dispersible Tablets (BROTOCEF-100 DT TABLETS) | CT1904EMfg 2019-12 · Exp 2021-11 | AssayAssay | RDTL ChandigarhCDSCO lab | Feb 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.